Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Correction: £3.75 Million Raised

30 Jun 2015 16:15

RNS Number : 7193R
Arria NLG PLC
30 June 2015
Β 

The following amendments have been made to the 'Β£3.75 Million Raised' announcement released on 29 June 2015 at 7:32 a.m. under RNS No 4652R.

Β 

- The calculation of the number of B Warrants to be issued to the Loan Note holders has been clarified

- The Update of the Capital Structure table has been amended to correct an erroneous figure and highlight that some of the figures are approximations.

Β 

All other details remain unchanged.

Β 

The full amended text is shown below.

Β 

Β 

Β 

ARRIA NLG PLC

Β 

Β ("Arria" or the "Company")

Β 

Β£3.75 Million Raised

Β 

The Board of Arria (AIM:NLG) is very pleased to announce that the Company has worked with a number of existing shareholders and subscribers (the "Subscribers") to gain immediate access to approximately Β£3.75 million in capital funding through unsecured loan notes convertible to the Company's ordinary shares at 40p per share ("Loan Notes").

Β 

This funding comes as stage one of a two-stage capital plan being managed for Arria by MSL Capital Markets Limited ("MSL"), the New Zealand-based investment bank whose principals have acted as lead manager on each of Arria's successful private capital rounds. In an undertaking provided by Arria to MSL and the Subscribers, the Board has confirmed that it fully supports the two stage capital plan.

Β 

Stage 1: Β£3.75 Million in Loan Notes

Β 

Stage 1 of the capital plan (which addresses the Company's near to medium-term working capital requirements) comprises the acceleration of a drawdown of existing Loan Notes and the issue of new Loan Notes as follows:

Β 

Β· Β£1.848 million from The Ikonic Fund SAC (Bahamas) Limited ("Ikonic") by way of Ikonic agreeing to the early drawdown of the two installments still to be drawn down under the unsecured convertible loan note instrument between the Company and Ikonic dated 30 September 2014 (the "Ikonic Notes"). These amounts were not due for drawdown until 31 December 2015 and 31 March 2016. The Company has agreed to pay certain costs which Ikonic will incur in allowing the Company to drawdown earlier than originally agreed; and

Β 

Β· Β£1.902 million through subscriptions for the new Loan Notes from existing shareholders in the Company. The new Loan Notes have the same terms and conditions as the Ikonic Notes.

Β 

Subscribers for the new Loan Notes and Ikonic will receive unlisted warrants to subscribe for new ordinary shares in the Company, exercisable for a period of four years, at 12p per new ordinary share (the "B Warrants"). The Company will issue 6 million B Warrants to Ikonic, for the Ikonic Notes drawn down early and approximately 5.972 million B Warrants to the new convertible Loan Note holders. An additional one million B Warrants will be issued to MSL for services. The number of B Warrants issued to the new convertible Loan Note holders may fluctuate depending upon the GBPΒ£/US$ exchange rate. This is because the quantum of B Warrants issued to the new convertible Loan Note holders is calculated on the basis of two B Warrants to every US$ of Loan Note subscribed.

Β 

The detailed terms of the Ikonic transaction were announced to the market on 1 October 2014. The following is a summary of terms common to both Loan Note programs.

Β 

Β· Interest at the Bank of England base rate (currently 0.5%) plus 5%, payable annually in cash or upon maturity.

Β 

Β· Maturity is 31 October 2019 with the Company having a right of payment before maturity.

Β 

Β· The conversion price is 40p per ordinary share. Holders can convert their principal and interest at any time before payment or maturity.

Β 

Stage 2: New Zealand Stock Exchange Listing

Β 

Stage 2 of the capital plan (which addresses the longer-term capital needs of the Company) is targeted for completion this year. It calls for MSL to organize a public offer and a listing of Arria's ordinary shares on the New Zealand Stock Exchange ("NZSX"). The Board will also consider alternative capital sources. Further announcements regarding fundraising will be made in due course.

Β 

Update of the Capital Structure

Β 

To ensure clarity and transparency of the Company's capital structure upon completion of Stage 1, the Company has prepared the following table showing the effect of the capital raise on the current position:

Β 

Arria NLG plc Securities

Nominal value

Note value

Number of shares

Existing ordinary shares

Β£103,729.21

103,729,210

Existing listed warrants

Β£10,085.58

10,085,583

The Ikonic Notes

-

Β£3.08 million

7,700,000(1)

The new Loan Notes

-

Β£1.902 million

4,755,000(1)

B Warrants

Β£12,972.28(2)

12,972,280(2)

(1) Assumes all loan notes are converted into Ordinary shares

(2) Assumes allotment at approximately US$1.57 / Β£, and all B Warrants are converted into Ordinary shares

The Board has authorized MSL to arrange subscriptions for up to a further Β£1.25 million of Loan Notes.

Β 

Emmanuel Alexiou, Executive Vice Chairman of Colina Insurance Limited (majority shareholder of The Ikonic Fund) said: "We are very pleased to support Arria's innovative two-stage capital program. With the loan notes convertible to shares at 40p, and with the addition of warrants at 12p, we are making a bold statement to the market: The long-term potential of Arria's NLG technologies is unaffected by short-term vagaries, and the two-stage program will provide the operating capital Arria needs to deliver its artificial intelligence solutions globally."

Β 

Stuart Rogers, Chairman and Chief Executive of Arria NLG, commented:

"I am delighted we have concluded this next stage of our capital raising, which provides stability and support to our current operations as it directly addresses our near to medium-term working capital requirements. The staff and Board wish to thank MSL, Ikonic and the founding shareholders for their participation in this capital raise. Such strong support of Arria's business direction is indicative of the participating shareholders' belief in the long term value proposition of Arria's Natural Language Generation technology."

Β 

Commercial Progress Update

Β 

The Company continues to gain clients at the rate of approximately one new client per month. Since the beginning of May, Arria has announced contracts with three new enterprise clients: a financial services group, a meteorological firm and a travel services company."

Β 

For further information, please visit www.arria.com or contact:

Β 

Arria NLG plc

Stuart Rogers - Chairman and Chief Executive

Β 

Tel +44 (0) 20 7100 4540

Allenby Capital - Nominated Adviser & Joint Broker

Nick Naylor

Jeremy Porter

James Reeve

Β 

Tel: +44 (0) 20 3328 5656

Β 

MSL Capital Markets - Lead Manager

Andrew McDouall

Justine Dunnett

Peter Lynds

Β 

Tel: +64 (0) 4 472 2716

Westhouse Securities - Joint Broker

Antonio Bossi

Robert Finlay

Β 

Tel: +44 (0) 20 7601 6100

IFC Advisory - Financial PR and IR

Tim Metcalfe

Graham Herring

Β Tel: +44 (0) 20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEEBLFXEQFFBBB
Date   Source Headline
12th Nov 20155:24 pmRNSHolding(s) in Company
6th Nov 20154:12 pmRNSResult of GM, funding update & total voting rights
30th Oct 20155:54 pmRNSTotal Voting Rights
20th Oct 20154:26 pmRNSPosting of Circular and Notice of General Meeting
20th Oct 201510:00 amRNSHolding(s) in Company
15th Oct 20157:00 amRNSSubscription agreement with Lanstead Capital
29th Sep 20157:00 amRNSGrant of Additional US Patent
14th Sep 201512:13 pmRNSBoard Appointment
2nd Sep 20151:47 pmRNSCapital Funding Update
21st Aug 20157:00 amRNSNew Agreement with a Consumer Goods Company
19th Aug 20158:56 amRNSFunding Update
4th Aug 201510:01 amRNSGrant of US patent
4th Aug 201510:00 amRNSFunding update
30th Jun 20154:15 pmRNSCorrection: £3.75 Million Raised
30th Jun 20154:15 pmRNSCorrection: Interim Results
30th Jun 20157:00 amRNSInterim Results
29th Jun 20157:32 amRNS£3.75 Million Raised
24th Jun 20157:00 amRNSFunding update
18th Jun 20157:00 amRNSNew Agreement with Major Online Travel Company
4th Jun 20154:40 pmRNSSecond Price Monitoring Extn
4th Jun 20154:35 pmRNSPrice Monitoring Extension
3rd Jun 20157:00 amRNSUpdate Regarding Further Funding
13th May 20154:40 pmRNSSecond Price Monitoring Extn
13th May 20154:35 pmRNSPrice Monitoring Extension
13th May 20157:00 amRNSProof of Concept Pilot Agreement
12th May 20154:40 pmRNSSecond Price Monitoring Extn
12th May 20154:35 pmRNSPrice Monitoring Extension
11th May 20157:00 amRNSLicensing Agreement with MeteoGroup UK
5th May 20157:02 amRNSExhibit at World of Watson
30th Apr 20157:00 amRNSRe Contract and Trading Update
8th Apr 20157:00 amRNSUK Met Office Contract Extension
23rd Mar 20157:00 amRNSFramework Licensing Agreement
3rd Mar 20157:00 amRNSBG Group. Heads of Agreement
2nd Mar 20157:00 amRNSFive Year Licensing Agreement with FarmLink, LLC.
27th Feb 201512:30 pmRNSTotal Voting Rights
4th Feb 20157:00 amRNSSubscription to raise £408,270
27th Jan 20152:32 pmRNSResult of AGM
27th Jan 20152:05 pmRNSAGM Statement
26th Jan 20157:00 amRNSIBM Watson Partnership Agreement
15th Jan 20157:00 amRNSNew Agreement with Major Insurance Company
17th Dec 20147:00 amRNSNew Oil & Gas Client
12th Dec 20147:00 amRNSFinal Results
14th Oct 20147:00 amRNSAgreement with Leading Aviation Systems Provider
13th Oct 20147:00 amRNSContract signed with FarmLink, Inc.
1st Oct 20147:00 amRNSConvertible loan notes to raise circa US$5.0m
9th Sep 20147:00 amRNSAIM Awards 2014 Nomination - Best Technology
12th Aug 20147:00 amRNSProject with Global Financial Services Company
25th Jun 20147:00 amRNSJohn Bell strengthens growing Sales Force
24th Jun 20147:00 amRNSAwarded two US Patents
23rd Jun 20143:10 pmRNSPosting of interim accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.